• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Italy·Healthcare·GPI.MI
Share

GPI S.p.A. Stocks

€ 14.9Last Updated 09.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Moderate

Recommendation

Hold

Market Cap

€ 464.40M

€ 14.9
Key Takeaways

Risk factor

Considerable default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

GPI S.p.A. delivers specialized IT and high-tech services to the healthcare and social-healthcare markets. The company develops a wide range of software solutions covering critical areas such as health administration, clinical systems, social care, blood and tissue banking, human resource management, continuum care, public administration, safety and prevention, chronic illness management, patient care, business intelligence, data analytics, health cooperation, and people relationship management. Beyond software, GPI delivers key healthcare administration services, including advanced centralized booking and contract systems designed to significantly reduce patient waiting times, alongside innovative healthcare technologies and broader healthcare support. Their product portfolio features the Phasys System, an integrated hardware and software platform for optimizing medication management in healthcare facilities, and the RIEDL Phasys System, which automates medicine distribution within pharmacies. Furthermore, GPI offers general ICT services, payment solutions for both public administration and retail, and a comprehensive suite of desktop services. These desktop services encompass the design, implementation, and ongoing maintenance of technological infrastructures; IT consultancy and support; provision of solutions for public administrations; and help desk and facility management for a diverse clientele including local and central public bodies, healthcare providers, multi-utilities, and private enterprises. They also specialize in trouble ticketing systems and the design of integrated technological solutions. Established in 1988 and headquartered in Trento, Italy, GPI S.p.A. operates as a subsidiary of FM S.r.l.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of GPI.MI is 18.8 and suggests 26.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

10.10.2026 16:01

What's Important in Small-Cap Stocks: Risks Associated with Webull, Levi's Outlook, and Vaxcyte's Success

10.10.2026 13:01

How soon will the AI bubble burst? Will France infect the Eurozone? What's wrong with Levi's jeans?

10.10.2026 06:47

Moderna hits four-year high as NYT reports U.S. cancer vaccine effort

10.10.2026 04:58

Palantir shares hit a new high: Barclays followed Goldman in recommending a buy

10.10.2026 04:25

Apple has cut orders for parts for the new iPhones, according to media reports. Was demand lower than expected?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026